January 24, 2025 - 13:32

Functional genomics plays a crucial role in unraveling the connections between genotype and phenotype in various diseases. By providing insights into the genetic basis of diseases, this field of study facilitates the identification of novel drug targets, ultimately enhancing the drug discovery process. As researchers delve deeper into the complexities of genetic information, they can uncover how specific genes contribute to disease mechanisms, paving the way for more effective therapeutic interventions.
Moreover, functional genomics aids in the understanding of existing drugs, allowing scientists to evaluate their efficacy and mechanisms of action at a molecular level. This knowledge not only helps in optimizing current treatments but also in predicting patient responses based on genetic variations. As the integration of functional genomics into drug discovery continues to evolve, it holds the promise of transforming the landscape of personalized medicine, enabling tailored therapies that cater to individual genetic profiles and improving patient outcomes.
February 3, 2026 - 13:55
SoftBank subsidiary to work with Intel on next-gen memory for AIA strategic partnership has been announced between Intel Corporation and a subsidiary of SoftBank Group, aiming to accelerate the commercialization of cutting-edge memory solutions specifically...
February 2, 2026 - 21:25
Disability studies professor explores 'double bind' of medical technology in new bookMedical technology is often viewed as a neutral tool for healing or curing; however, for many disabled people, it represents a complex power dynamic between their own lived experiences and clinical...
February 2, 2026 - 03:07
Mizuho lifts Micron Technology, Inc. (MU)’s price target to $480, maintains outperform ratingInvestment firm Mizuho Securities has significantly increased its price target for Micron Technology, Inc. (MU), expressing strong confidence in the memory chipmaker`s financial trajectory. The...
February 1, 2026 - 03:04
A $1,000 Seed in Micron 42 Years Ago Would Have Blossomed into a FortuneThe staggering returns from early investments in technology titans are coming into focus, with Micron Technology serving as a prime example. A modest investment made decades ago would have yielded...